Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-03-16

Clinical Trial Update: A Clinical Trial to Examine the Efficacy and Safety of an Investigational Product With and Without Use of Semaglutide on Glycemic Response in Adults With Prediabetes or Type 2 Diabetes [NA]

View source ↗

Summary

This ClinicalTrials.gov entry describes a study evaluating the efficacy and safety of an investigational product with and without semaglutide on glycemic respon…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Investigational product (undisclosed)
  • semaglutide (semaglutide)

Snippet

Sponsor: QuickSilver Scientific | Conditions: Prediabetes / Type 2 Diabetes | NA | Status: RECRUITING